Pipeline challenges

摘要

Admittedly, analyzing a drug company’s pipeline is more than just a numbers game. Nevertheless, like some sort of pharmaceutical industry numerology, the figures do tell a story about size and productivity. What numbers alone can’t foretell, however, are the quality, value, and chances for success of drug candidates, or the strategies major drug firms are trying to fill and advance their pipelines.